ATR 1072 in Participants With PRKAG2 Syndrome
NCT07738107
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
37
Enrollment
INDUSTRY
Sponsor class
Conditions
Cardiac Glycogenosis
Cardiomyopathy
Hypertrophic
Wolff-Parkinson-White Syndrome
Interventions
DRUG:
ATR 1072
Sponsor
Atrium Therapeutics